Skip to main content
Premium Trial:

Request an Annual Quote

... As Canadian Gov t Awards Cepheid, Public Health Agency $675K to Develop Pathogen Detection Tech

NEW YORK, Feb. 14 (GenomeWeb News) - The Canadian government has awarded Cepheid and the Public Health Agency of Canada CA$780,000 ($675,000) to develop in-field nucleic acid assays for Ebola, Marburg, and Lassa fever viruses, Cepheid said today.


Under the agreement, Cepheid and the Public Health Agency of Canada's National Microbiology Laboratory will develop the assays over a 2-year period based on Cepheid's GeneXpert technology.


The grants will be awarded from Canada's Chemical, Biological, Radiological, and Nuclear Research and Technologies Initiative, which comprises 14 government science-based and security departments and agencies.


Cepheid will retain the rights to the developed technology along with product distribution rights, it said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.